Acute Porphyria Drugs

J05AB14 - Valganciclovir

Not porphyrinogenic
NP

Rationale
Prodrug converted by intestinal and hepatic esterases to ganciclovir, which is not further metabolised.
Chemical description
L-valinate ester of the antiviral ganciclovir used to prevent CMV-infection in CMV-negative patients receiving organ transpalantate from CMV positive donor. Rapidly and completely metabolized by intestinal and hepatic esterases to ganciclovir.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J05A / J05AB or go back.
References
Tradenames

Alvanocyt · Valcyte · Valdamin · Valganciclovir · Wirnazir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valdamin · Valganciklovir Valcyte · Valganciclovir Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Ceglar · Valcyclox · Valcyte · Valhit Valcyte · Valganciclovir Valcyte Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte · Valganciclovir Valcyte Ganaxa · Valcyte · Valganciklovir Valganciclovir
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙